share_log
Benzinga ·  Apr 30 07:06
Nautilus Biotechnology's Cash, Cash Equivalents, And Investments Were $247.7M As Of March 31, 2024
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment